Vireo Growth Inc

CSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026

Company Profile

IndustryDrug Manufacturers - Specialty & Generic

SectorHealthcare

ExchangeCSE

Market Capitalization570.77 mln

Float32.44 mln

Earnings Date11/18/2026

Piotroski F-Score

4 / 9

Borderline

Beneish M-Score

-0.45

Highly suspicious

Relative Strength

33 / 100

Underperforming

Debt / Equity

1.10

Elevated leverage

Pre-Tax Margin

-3%

Barely loss-making

ROE

-21.35

Deeply negative

Key Fundamentals

EPS-2.35

ROE-21.35

ROIC4.58

ROA-7.57

Interest Cover1.07

EBITDA, mln70.23

EV / EBITDA15.36

EV / EBIT43.34

Revenue, mln707

EV / Revenue1.52

Quote Details

Last 10.44

Change -0.44 (-4.04%)

Open 10.53

Volume 32,285

Turnover 337,055

Average Volume 17,483

Financial Ratios

Pre-Tax Profit Margin-3

Current Ratio1.01

Price / Book0.82

Price / Tangible Book5.77

Debt / Equity1.10

Price / Sales0.60

Financial Strength

Altman Z-Score0.38

Piotroski F-Score 4 / 9

Beneish M-Score-0.45

Price Performance & Relative Strength

Period	Price Performance	Relative Strength
1 Week	-8.74%	38 / 100
1 Month	-25.43%	37 / 100
2 Months	-23.91%	48 / 100
6 Months	-42%	46 / 100
1 Year	-58.07%	30 / 100